Evidence map›Paper›PMID 32041339›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Toward Large-Scale Production of Oxidized Graphene.

Talia Tene, Gabriela Tubon Usca, Marco Guevara, Raul Molina, Francesco Veltri, Melvin Arias, Lorenzo S Caputi, Cristian Vacacela Gomez

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Preparation of LaMniScience · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Temperature-Dependent Optical Properties of Oxidized Graphenes.Nanomaterials (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Talia TeneDepartment of Chemistry and Exact Sciences, Universidad Técnica Particular de Loja, Loja EC-110160, Ecuador.
Gabriela Tubon UscaFaculty of Science & Mechanical Engineering, Escuela Superior Politécnica de Chimborazo, Riobamba EC-060155, Ecuador.
Marco GuevaraFaculty of Science & Mechanical Engineering, Escuela Superior Politécnica de Chimborazo, Riobamba EC-060155, Ecuador.ORCID 0000-0003-2599-3312
Raul MolinaGraphenTech NL, Olympiaweg 28A, 3077AL Rotterdam, The Netherlands.
Francesco VeltriUNICARIBE Research Center, University of Calabria, I-87036 Rende (CS), Italy.
Melvin AriasUNICARIBE Research Center, University of Calabria, I-87036 Rende (CS), Italy.
Lorenzo S CaputiUNICARIBE Research Center, University of Calabria, I-87036 Rende (CS), Italy.
Cristian Vacacela GomezUNICARIBE Research Center, University of Calabria, I-87036 Rende (CS), Italy.ORCID 0000-0002-9248-9944

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oxidative exfoliation of graphite is a promising approach to the large-scale production of graphene. Conventional oxidation of graphite essentially facilitates the exfoliation process; however, the oxidation procedure releases toxic gases and requires extensive, time-consuming steps of washing and reduction to convert exfoliated graphene oxide (GO) into reduced graphene oxide (rGO). Although toxic gases can be controlled by modifying chemical reactions, filtration, dialysis, and extensive sonication are unfavorable for large-scale production. Here, we report a complete, scalable, and green synthesis of GO, without NaNO

Indexed as

citric acidgraphenelarge-scale productionoxidized graphene

Identifiers

PMID32041339
PMCPMC7075232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.